Schiff Base Derivatives of Benzothiazole and Benzamide as Promising Antimicrobial Agents: Integrated In Silico and In Vitro Evaluation
ChemMedChem · 2026
DOI: 10.1002/cmdc.70499 ↗At a glance
Journal article in ChemMedChem, 2026. Written by Temitope A Ogunnupebi and 6 co-authors. Institution: Covenant University Bioinformatics Research (CUBRe), Covenant University, Ota, Nigeria. Major MEDLINE topics: Benzothiazoles, Benzamides, Antifungal Agents, Anti-Bacterial Agents. 56 references. The full text is freely available in PubMed Central. Funded by: FIC NIH HHS, Royal Society of Chemistry, Fogarty International Center.
Abstract (original language)
Antimicrobial resistance (AMR) remains a critical global health challenge, demanding new scaffolds with potent and broad‐spectrum activity. In this work, a library of Schiff‐base derivatives of benzothiazoles ( 2a–2f ) and benzamides ( 5a–5i ) was designed, synthesised via a microwave‐assisted approach, and comprehensively characterised by 1 H‐/ 13 C‐NMR, FT‐IR, and UV–Vis spectroscopy. In silico ADMET profiling predicted favourable pharmacokinetics and low toxicity. Molecular docking of the compounds against E. coli glucosamine‐6‐phosphate synthase (2VF5) and C. albicans lanosterol 14α‐demethylase (5V5Z) revealed strong binding affinities, surpassing ciprofloxacin and fluconazole. Compounds 5f and 2f (−8.1 and −8.0 kcal/mol) for 2VF5, while 2a and 5h had good binding affinity (−9.7 and −9.6 kcal/mol) for 5V5Z, showing optimal interactions with key catalytic residues, maintaining structural stability in molecular dynamics simulations. Consistent with these predictions, compounds 5h, 5f, and 2a exhibited potent antibacterial activity (MIC: 3.13–12.5 µg/mL) against both Gram‐positive and Gram‐negative strains, and antifungal activity (MIC: 6.25–12.5 µg/mL against C. albicans and A. fumigatus ). Structure–activity relationship (SAR) analysis revealed that aryl substitution influenced bioactivity, with 4‐ethoxy ( 5h ), 2‐hydroxy ( 5f ), and 2‐fluoro ( 2a ) groups being active, whereas unsubstituted analogues were inactive. These compounds are highlighted as promising antimicrobial leads requiring further in vivo evaluation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Covenant University Bioinformatics Research (CUBRe), Covenant University, Ota, Nigeria.
- Department of Chemistry, Covenant University, Ota, Ogun State, Nigeria.
- West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon, Accra, Ghana.
- Department of Chemistry, University of Pretoria, Hatfield, South Africa.
- African Center of Excellence in Bioinformatics and Data Intensive Science, Makerere University, Kampala, Uganda.
- Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID profiles: Temitope A Ogunnupebi, Gbolahan O Oduselu, Oluwadunni F Elebiju, Oluwabukayo T Opebiyi, Natasha October, Olayinka O Ajani
Funding
- FIC NIH HHS
- Royal Society of Chemistry
- Fogarty International Center
Cite
APA
Ogunnupebi, T. A., Oduselu, G. O., Elebiju, O. F., Opebiyi, O. T., October, N., Ajani, O. O., & Adebiyi, E. (2026). Schiff Base Derivatives of Benzothiazole and Benzamide as Promising Antimicrobial Agents: Integrated In Silico and In Vitro Evaluation. ChemMedChem. https://doi.org/10.1002/cmdc.70499
Vancouver
Ogunnupebi TA, Oduselu GO, Elebiju OF, Opebiyi OT, October N, Ajani OO, et al. Schiff Base Derivatives of Benzothiazole and Benzamide as Promising Antimicrobial Agents: Integrated In Silico and In Vitro Evaluation. ChemMedChem. 2026. doi:10.1002/cmdc.70499
BibTeX
@article{Ogunnupebi2026,
author = {Ogunnupebi, Temitope A and Oduselu, Gbolahan O and Elebiju, Oluwadunni F and Opebiyi, Oluwabukayo T and October, Natasha and Ajani, Olayinka O and Adebiyi, Ezekiel},
title = {Schiff Base Derivatives of Benzothiazole and Benzamide as Promising Antimicrobial Agents: Integrated In Silico and In Vitro Evaluation},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70499}
}
EUVIMED